Which chemoreceptors in the central nervous system are crucial for activation of vomiting?

Which chemoreceptors in the central nervous system are crucial for activation of vomiting?

• A. 5HT, DA, NK1
• B. D2, 5HT3, NK1
• C. D2, Substance P, Acetylcholine
• D. 5HT3, Acetylcholine, DA

Answer: (B)

The correct selection identifies the specific chemoreceptors in the central nervous system that play a significant role in the activation of vomiting. The D2 (dopamine), 5HT3 (serotonin), and NK1 (neurokinin-1) receptors are all critically involved in the vomiting reflex. Dopamine receptors, particularly D2, are involved in the chemoreceptor trigger zone (CTZ) response to certain stimuli, including drugs and toxins, which can trigger nausea and vomiting. The activation of these receptors leads to a cascade of neurochemical signaling that ultimately results in the act of vomiting. The 5HT3 receptors are primarily activated by serotonin, which can be released in the gastrointestinal tract and from the central nervous system. This pathway becomes particularly important in the context of chemotherapy-induced nausea and vomiting because many anti-cancer drugs lead to the release of serotonin, prompting vomiting through these receptors. NK1 receptors are designed to respond to substance P, which is a neuropeptide that plays a critical role in relaying pain and anxiety signals. In the context of vomiting, activation of NK1 receptors significantly contributes to the overall vomiting response, particularly in the setting of motion sickness and chemotherapy. This combination of D2,

The correct selection identifies the specific chemoreceptors in the central nervous system that play a significant role in the activation of vomiting. The D2 (dopamine), 5HT3 (serotonin), and NK1 (neurokinin-1) receptors are all critically involved in the vomiting reflex.

Dopamine receptors, particularly D2, are involved in the chemoreceptor trigger zone (CTZ) response to certain stimuli, including drugs and toxins, which can trigger nausea and vomiting. The activation of these receptors leads to a cascade of neurochemical signaling that ultimately results in the act of vomiting.

The 5HT3 receptors are primarily activated by serotonin, which can be released in the gastrointestinal tract and from the central nervous system. This pathway becomes particularly important in the context of chemotherapy-induced nausea and vomiting because many anti-cancer drugs lead to the release of serotonin, prompting vomiting through these receptors.

NK1 receptors are designed to respond to substance P, which is a neuropeptide that plays a critical role in relaying pain and anxiety signals. In the context of vomiting, activation of NK1 receptors significantly contributes to the overall vomiting response, particularly in the setting of motion sickness and chemotherapy.

This combination of D2,